KK
Keisei Kawa

Elite Scholar

170
Works
6,793
Citations
41
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5112509058
  • i10-Index 86
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Keisei Kawa

Also known as: K Kawa, KEISEI KAWA, Kawa, Keisei, Keisei KAWA, Keisei Kawa

170

Total Works

6,793

Citations

41

H-Index

86

i10-Index

Citation & Works Trend by Year
40 years active
Top Research Topics
Hematopoietic Stem Cell Transplantation (75) Viral-associated cancers and disorders (50) Lymphoma Diagnosis and Treatment (32) Acute Lymphoblastic Leukemia research (31) Immunodeficiency and Autoimmune Disorders (30)
Recent Publications
15 shown
Year Publication Title Citations Action
2023 Supplementary Figure 1 from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2023 Supplementary Figure Legend from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2023 Data from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2023 Data from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2023 Supplementary Figure 1 from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2023 Supplementary Figure Legend from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 0
2022 Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015 Cancer Science 8
2021 Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy International Journal of Clinical Oncology 46
2021 Measurable residual disease-based strategy and reduced-intensity hematopoietic stem cell transplantation for acute myelogenous leukemia in children 0
2021 Trends in survival of leukemia among children, adolescents, and young adults: A population‐based study in Osaka, Japan Cancer Science 23
2020 Impact of melphalan dose during reduced‐intensity conditioning on engraftment of cord blood transplantation for chronic Epstein‐Barr virus‐associated T or NK cell lymphoproliferative diseases Pediatric Blood & Cancer 3
2020 Dynamics of Epstein-Barr virus after cord blood transplantation: A nationwide survey in Japan BLOOD CELL THERAPY / The official journal of APBMT 1
2019 Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy Nature Microbiology 8
2019 Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan International Journal of Hematology 7
2019 Defective Epstein–Barr virus in chronic active infection and haematological malignancy Nature Microbiology 238

Data source: OpenAlex API